Back to all peptides
✨ real molecule sketch
See this name online?
CJC-1295
Fitness peptides are often sold for “research use”—learn the compound before trusting a label.
Structure (cute edition)
✨ real molecule sketch
This peptide is a short chain of about 4 amino acids—think of it as a tiny protein necklace on your label.
INCI: CJC-1295 · ~4 amino acids in our simplified view
Research & public records
Counts and links from public databases (PubMed, ClinicalTrials.gov, Wikidata, NIH drug nomenclature). Educational only — not medical advice.
Knowledge base: chemical compound — Wikipedia
PubMed: 31 indexed papers (search PubMed)
- Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications. · JBJS reviews
- Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives. · International journal of molecular sciences
- Therapeutic peptides in gerontology: mechanisms and applications for healthy aging. · Frontiers in aging
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. · Sports medicine (Auckland, N.Z.)
- A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review. · The Journal of sports medicine and physical fitness
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. · The American journal of sports medicine
- Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry. · Journal of pharmaceutical and biomedical analysis
Clinical trials: 73 studies on ClinicalTrials.gov (view search)
- A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity · TERMINATED
- A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer · TERMINATED
- A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy · COMPLETED
- A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast Cancer · COMPLETED
- Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer · COMPLETED
- TRial on the Endocrine Activity of Neoadjuvant Degarelix · COMPLETED
- A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer · NOT_YET_RECRUITING
- Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate · COMPLETED
ChEMBL: CHEMBL5927611
What brands say it does
CJC-1295 mimics growth hormone-releasing hormone. The DAC version binds albumin for a longer half-life. Intended effects: lean mass support, sleep quality, and recovery. Prescription analogs exist in different forms; gray-market versions vary in purity.
Where you’ll find it
Peptide therapy clinics and performance optimization protocols.
Other names you might see
Modified GRF 1-29
DAC CJC-1295
Growth hormone releasing hormone analog
Compare with similar peptides
Similar peptides
Educational only—not medical advice. Many compounds here are banned in sport and not FDA-approved for OTC use.